When investors like Alex Denner (The 25 most influential people in biopharma today) dumping shares for loss, it has to be something wrong with the science. Perhaps ADXS share price will double/or triple overnight if Advaxis simply rename their crappy/outdated LM-based immunotherapy to something like blockchain-based immunotherapy :)